Why the study?
Are DOACs effective and safe in elderly patients with nonvalvular atrial fibrillation and renal dysfunction?
Are DOACs effective and safe in elderly patients with nonvalvular atrial fibrillation and renal dysfunction?
DOACs appear effective and safe for stroke prevention in elderly patients with nonvalvular atrial fibrillation, even in the presence of significant renal dysfunction (CrCl 15-<50 mL/min).
Answers are grounded in this paper and cite their sources.
May support DOAC use in elderly AF with moderate renal dysfunction; leaves open need for randomized confirmation.
Incidences of major clinical outcomes increased with decreasing renal function in elderly nonvalvular atrial fibrillation patients. DOACs were effective and safe even in patients with renal dysfunction (CrCl 15-<50 mL/min). (Prospective Observational Study in Late-Stage Elderly Patients with Non-Valvular Atrial Fibrillation: All Nippon AF In Elderly Registry [ANAFIE Registry]; UMIN000024006).
No takes yet. Share an insight, caveat, or question.
Shimizu et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: